Early stage cervical cancer with negative pelvic lymph nodes: Pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy

Purpose of investigation: The objective was to optimize the adjuvant treatment for patients with lymph node negative cervical cancer by analyzing patterns of failure and complications following radical hysterectomy and adjuvant radiotherapy.

Methods: From September 1992 to December 1998, 67 patients with lymph node negative uterine cervical cancer (FIGO stage distribution: 50 Ib. 17 IIa), who had undergone radical hysterectomy and postoperative adjuvant radiotherapy with a minimum of three years of follow-up were evaluated. All patients received 50-58 Gy of external radiation to the lower pelvis followed by two sessions of intravaginal brachytherapy with a prescribed dose of 7.5 Gy to the vaginal mucosa. For 21 patients with lymphovascular invasion, the initial irradiation field included the whole pelvis for 44 Gy. The data were analyzed for actuarial survival (AS), pelvic relapse-free survival (PRFS), distant metastasis-free survival (DMFS), and treatment-related complications. Multivariate analysis was performed to assess the prognostic factors.

Results: The respective five-year AS, PRFS, and DMFS for the 67 patients were 79%, 93% and 87%. Multivariate analysis identified two prognostic factors for AS: bulky tumor vs non-bulky tumor (p = 0.003), positive resection margin (p = 0.03). The independent prognostic factors for DMFS was bulky tumor (p = 0.003), while lymphatic permeation showed marginal impact to DMFS (p = 0.08). The incidence of RTOG grade 1-4 rectal and non-rectal gastrointestinal complication rates were 20.9% and 19.4%, respectively. The independent prognostic factor for gastrointestinal complication was age over 60 years (p = 0.047, relative risk 4.1, 95% CI 1.2 approximately 11.7). The incidence of non-rectal gastrointestinal injury for the patients receiving whole pelvic radiation and lower pelvic radiation was 28.5% and 15.2%, respectively (p = 0.25).

Conclusion: For patients with lymph node negative cervical cancer following radical hysterectomy, adjuvant lower pelvic radiation appears to be effective for pelvic control. It is also imperative to intensify the strategies of adjuvant therapy for some subgroups of patients.

Cervical cancer; Negative lymph node; Adjuvant radiotherapy; Radiation morbidity

[1] Hatch K. D.: "Cervical Cancer". In: Berek J. S,, Hacker N. F (eds.): Practical Gynecologic Oncology. 2"' ed., Williams & Wilkins, 1994, 249.

[2] Perez C. A.: "Uterine Cervix: Principles and Practice of Radiation Oncology". 3''ed., Philadelphia,P A,L ippincott-Raven, 1998, 1751.

[3] Yeh S. A., Leung S. W., Wang C. J., Chen H. C.: "Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors". Gynecol. Oncol., 1999, 72, 10.

[4] Lai C.H.,H ong J. H.,H sueh S.,N g K. K.,C hang T. C., Tseng C. J., Chou H. H. et al.: "Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage 1B or II cervical patients with or without pelvic lymph node metastases". Cancer, 1999, 7, 1537.

[5] Kamura T., T sukamoto N., T suruchi N., Saito T., Matsuyama T., Akazawa K. et al.: "Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy". Cancer, 1992, 69, 181.

[6] Gonzalez D., Ketting B. W., van Bunnigen B., van Dijk J. D ''Carcinoma of the uterine cervix stage 1B and IIA: results of postoperative irradiation in patients with microscopic infiltration in the parametrium and/or lymph node metastases". Int. J. Radiat Oncol. Biol. Phys., 1989, 16, 389.

[7] Hopkins M. P., Morley G. W.: "Stage IB squamous cell cancer of cervix: clinical pathologic features related to survival". Am. J Ohstet. Gynecol. Oncol., 1989, 35. 130.

[8] Fuller A. F. Jr., Elliott N., Kosloft、C.. Hoskins W. J., Lewis J. L Jr.: "Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage 1B and IIA carcinoma of the cervix". Gynecol. Oncol., 1989. 33, 34.

[9] Monk B. J., Cha D. S., Walker J. L., Burger R. A., Ramsingham N. S., Manetta A. et al.: "Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage 1B and IIA cervical carcinoma". Gynecol. Oncol., 1994, 54, 4.

[10] Burke T. W.,H oskins W. J.,H eller P. B., Bibro M. C., Weiser E B.. Park P. C.: "Prognostic factors associated with radical hysterectomy failure''. G_vnecol. Oncol., 1987, 26, 153.

[11] Delgado G.. Bundy B.. Zaino R., Swvin B.. Creasman W. T., Major E.: ·'Prospective surgical-pathological study of disease-free interval in patients with stage 1B squamous cell carcinoma of the cervix: A gynecologic oncology group study". Gynecol. Oncol., 1990, 38, 352.

[12] Fioricca J. V.. Roberts W. S., Greenberg H.. Hoffmann M. S., LaPolla J.P., Cavanagh D.: "Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy". Gynecol. Oncol., 1990, 36, 343.

[13] Barter J. F. , Soong S. J., Shingleton H. M., Hatch K. D., Orr J. W.: "Complications of combined radical hysterectomy and postoperative radiation therapy in women with early stage cervical cancer" Gynecol. Oncol., 1989, 32, 292.

[14] Cunningham M. J.,D unton C. J.,C orn B.,N oumoff J.. Morgan M A., King S. et al.: "Extended field radiation therapy in early-stage cervical carcinoma: survival and complications". Gynecol. Oneal., 1991, 43, 51.

[15] Cox J. D., Stetz J., Pajak T. F.: "Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)". Int. J. Radiat. Oneal. Biol. Phys., 1995, 31, 1341.

[16] Schorge J. O., Molpus K. L., Koelliker D., Nikrui N.. Goodman A., Fuller A. F.: "Stage 1B and TIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectorny". Gynecol. Oncol., 1997, 66, 31.

[17] Samlal R. A. K.. Velden J. V. D.. Ten Kate F. J. W., Schilthuis M. S.. Hart A. A. M., Lammes F. B.: "Surgical pathological factors that predict recurrence in stage 1B and llA cervical carcinoma patients with negative pelvic lymph nodes". Cancer. 1997. 80, 1234.

[18] Takamura A., Mizoe J., Arimoto T.. Kamada T., Shirato H., Matsuoka Y. et al.: "Is postoperative radiotherapy beneficial in the management of stage I-TT squamous cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement? A retrospective review of 70 patients". Asia-Oceania J. Obstet. Gynecol., 1993, 9, 145.

[19] Sartoli E.,L a Face B.,B azzurini L.. Fallo L.,P ecorelli S., Bianchi U. A.: "Pattern of failure in Stage IB-IIA cervical cancer after radical hysterectomy (abstract 51)". Int. J. Gynecol. Cancer, 1995, 5 (suppl.), 15.

[20] Thomas G. M., Dembo A. J.: "Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer". Int. J. Gynecol. Cancer, 1991, 1, 1.

[21] Kridelka F. J.. Berg D. 0.. Neuman M., Edwards L. S., Robertson G., Grant P. T. et al.: "Adjuvant small field pelvic radiation for patients with high risk, stage 1B lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection". Cancer, 1999, 86, 2059.

[22] Morris M., Eifel P. J.. Lu J., Grigsby P. W., Levenback C., Stevens R. E. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.

[23] Rose P. G.. Bundy B. N.. Watkins E. B., Thigpen J. T., Deppe G., Maiman M. A. et al.: "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl J. Med., 1999, 340, 1143.

[24] Vavra N., Sevelda P., Seifert M., Timar J., Kudielka I., Kucera H " The value of adj u vant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage TB with negative lymph nodes". Strahlenther. Onkol., 1992, 168, 524.